Overview Request Sample Pages Request Customization Download PDF
You are viewing: North America Microfluidics Market analysis
Part of: Microfluidics Market (Global)

The North America Microfluidics Market was valued at $104.6 Million in 2025 and projected to reach to $114.9 Million by 2030, representing a compound annual growth rate of 1.9%. North America's microfluidic components market demonstrates steady but conservative growth, driven by established healthcare infrastructure and continuous innovation in diagnostic and therapeutic applications.

North America Microfluidics Market (2025-2030) : Size and Share
logo-mobile
CAGR of
cagr-Chart
USD Million
MARKET SNAPSHOT
Market Size in USD 26.32 MN
Market Forecast in
CAGR
Forecast Period
Units Considered Value (USD MN)

North America Microfluidics Market Trends and Insights

  • This category encompasses ancillary devices and supporting technologies that enable microfluidic systems to function effectively across diagnostic, therapeutic, and research applications.
  • Other Microfluidic Components are projected to grow modestly to $114.9 million by 2030, reflecting steady but measured adoption driven by incremental improvements in manufacturing and integration capabilities. The segment's 1.9% compound annual growth rate indicates that Other Microfluidic Components are maturing within the healthcare ecosystem, with growth constrained by market saturation in certain applications and competition from integrated solutions.
  • Other Microfluidic Components serve critical roles in point-of-care testing, lab-on-chip systems, and pharmaceutical development, yet their expansion remains slower than the overall microfluidics market at 8.3% CAGR.
  • Between 2025 and 2030, Other Microfluidic Components will continue to support innovation in personalized medicine and decentralized diagnostics, though their market share may consolidate as larger component manufacturers integrate these functions into unified platforms..

Key Market Statistics

  • CAGR (2025-2030) 1.9% CAGR
  • Market Size, 2025 ~USD 104.6 Million
  • Forecast, 2030 ~USD 114.9 Million
  • Geography North America

North America Microfluidics Market Overview

Modest Growth Trajectory :

North America's microfluidic components market is projected to grow from $104.6 million in 2025 to $114.9 million by 2030, representing a CAGR of 1.9%, significantly below the global average of 8.3%.

US Market Dominance :

The United States represents the largest microfluidics market in North America at $13,146.8 million, driven by advanced healthcare infrastructure, R&D investments, and adoption of point-of-care diagnostics.

Canadian Growth Opportunity :

Canada's microfluidics market valued at $2,017.3 million offers steady expansion potential through increased pharmaceutical research, personalized medicine initiatives, and government healthcare technology investments.

Mature Market Characteristics :

North America's lower CAGR reflects market maturity with established players, regulatory frameworks, and saturated diagnostic applications, contrasting with emerging regions experiencing rapid adoption.

North America Microfluidics Market Dynamics

  • The region benefits from strong R&D capabilities, regulatory clarity, and high adoption rates among clinical laboratories and pharmaceutical companies.
  • However, market maturity and competitive saturation limit aggressive expansion compared to emerging markets.
  • The 1.9% CAGR reflects incremental improvements in existing applications rather than breakthrough innovations.
  • Strategic focus on miniaturization, cost reduction, and integration with digital health platforms will sustain growth through 2030..

Related Ecosystem

Analytical And Scientific Instrumentation

Top Technologies
  • Environmental Testing
  • Gas Chromatography
  • Polymerase Chain Reaction (PCR)
  • Automated Liquid Handling Systems
  • Flow Cytometry
Top Companies
  • Thermo Fisher Scientific Inc.
  • Danaher Corporation
  • Agilent Technologies, Inc.
  • Shimadzu Corporation
  • Merck KGaA

    Key Takeaways

    • Other Microfluidic Components are valued at $104.6 million in 2025 and expected to reach $114.9 million by 2030, growing at a modest 1.9% CAGR.
    • Other Microfluidic Components grow significantly slower than the overall microfluidics market (8.3% CAGR), indicating market maturation and consolidation.
    • Other Microfluidic Components face competitive pressure from integrated microfluidic platforms that combine multiple functions into single devices.
    • Other Microfluidic Components remain essential for point-of-care diagnostics, lab-on-chip applications, and pharmaceutical research despite slower growth rates.

    Microfluidics Market Report Scope

    Report Metric Details
    Base Year 2025
    Fastest Growing Segment PCR SYSTEMS (Device)
    Forecast Period 2025–2030
    Growth Rate CAGR of 8.3% from 2025 to 2030
    Largest Segment MICROFLUIDICS-BASED DEVICES (Product)
    Market Size Base Year (Billions) ~USD 24.96 (2025)
    Revenue Forecast (Billions) ~USD 37.19 (2030)
    Segments Covered Product, Device, Type, Material, Application, End User

    North America Microfluidics Market Report Segmentation

    6 segment dimensions are covered across the global market.

    By Product

    • Microfluidic
    • Microfluidic Components
    • Microfluidics-Based Devices

    By Device

    • Droplet & Particle Production System
    • Droplet & Particle Production Systems
    • Microfluidic Capillary Electrophoresis
    • Next-Generation Sequencing Systems
    • Ngs Systems
    • Other Devices
    • Pcr Systems

    By Type

    • Capillary Electrophoresis
    • Cell-Based Assays
    • Clinical Diagnostics
    • Drug Delivery
    • Flow & Pressure Controllers
    • Flow & Pressure Sensors
    • Genomic Analysis
    • Lab Analytics
    • Microdispensing
    • Microfluidic Chips
    • Microfluidic Valves
    • Microneedles
    • Micropumps
    • Microreactors
    • Other Microfluidic Components
    • Poct
    • Point-Of-Care Testing
    • Proteomic Analysis
    • Veterinary Diagnostics
    • Wearable

    By Material

    • Cyclic Olefin Copolymers
    • Glass
    • Other Materials
    • Polydimethylsiloxane
    • Polymethyl Methacrylate
    • Silicon

    By Application

    • Ivd
    • Pharmaceutical & Life Science Research
    • Therapeutics

    By End User

    • Academic & Research Institutes
    • Hospitals & Diagnostic Centers
    • Pharmaceutical & Biotechnology Companies

    Target Audience

    • Medical Device Manufacturers : Require detailed North American market sizing and growth forecasts to develop product portfolios, establish distribution networks, and compete effectively in the mature US and Canadian healthcare sectors.
    • Pharmaceutical & Biotech Companies : Need market intelligence on microfluidic component adoption rates and trends to optimize drug development workflows, diagnostic integration, and personalized medicine initiatives across North America.
    • Healthcare Investors & PE Firms : Utilize country-level market data and CAGR projections to evaluate acquisition targets, assess portfolio company growth potential, and identify consolidation opportunities in North American microfluidics.
    • Clinical Laboratory Networks : Require market insights on component availability, pricing trends, and technological advancements to upgrade diagnostic capabilities and maintain competitive advantage in point-of-care testing.
    • Research Institutions & Universities : Need market context on microfluidic component commercialization and adoption patterns to guide research priorities, secure funding, and translate innovations into North American clinical applications.

    Key Companies in the North America Microfluidics Market

    CompanyHQOwnershipStrongest segments
    BECKMAN COULTERUnited StatesPrivate CompanyChips,Sensors,Valves,
    RAINDANCE TECHNOLOGIESUnited StatesPrivate CompanyChip,Sensor,Valve,
    HALMA PLCUnited KingdomPublic CompanySensor,Valve,Pump,
    X-FABGermanyPublic CompanyChip,Sensor,Valve,
    TECHNICOLOR SAFrancePublic CompanyChip,Sensor,Valve,
    MAXCYTE, INCUnited StatesPublic CompanyMicrofluidic Chips and Cell-Handling Cartridges (linked to ExPERT PAs),Electroporation Instruments (ExPERT ATx, STx, GTx, VLx),Buffers, Software Protocols, and Accessories,
    DANAHER CORPORATIONUnited StatesPublic CompanyMicrofluidic Chips & Cartridges,Microfluidic Sensors,Microfluidic Valves & Pumps,
    ILLUMINA, INC.United StatesPublic CompanyMicrofluidic Chips (including flow cells and integrated cartridges),Microfluidic Sensors,Microfluidic Valves and Pumps,
    BIOMÉRIEUXFrancePublic CompanyChip,Sensor,Valve,
    THERMO FISHER SCIENTIFIC INC.United StatesPublic CompanyMicrofluidic Chips,Sensors,Valves,
    ABBOTT LABORATORIESUnited StatesPublic CompanyChip,Sensor,Valve,
    PARKER HANNIFIN CORPUnited StatesPublic CompanyValves,Pumps,Sensors,
    SMC CORPORATIONUnited StatesPublic CompanyAI and HPC servers for life-science workloads,Rack-scale solutions for hospital and diagnostic datacenters,Embedded and edge (5G/IoT/Edge) systems,
    IDEX CORPORATIONUnited StatesPublic CompanyPumps,Valves,Sensors,
    FORTIVEUnited StatesPublic CompanyChip-adjacent instrumentation and test,Sensor and pump calibration tools,Sterilization and instrument tracking (microfluidic-enabled devices),
    REVVITY, INC.United StatesPublic CompanyMicrofluidic Chips,Sensors,Valves,
    AGILENT TECHNOLOGIES, INC.United StatesPublic CompanyChip,Sensor,Valve,
    BIO-RAD LABORATORIES, INC.United StatesPublic CompanyChips,Sensors,Valves,
    BECTON, DICKINSON AND COMPANYUnited StatesPublic CompanyChip,Sensor,Valve,
    STANDARD BIOTOOLSUnited StatesPublic CompanyMicrofluidic Chips & Consumables,Microfluidic Instruments & Systems,Services, Software & Licensing,

    BECKMAN COULTER

    Beckman Coulter is a United States-based diagnostics and life sciences company founded in 1935 with 11,900 employees. As a private company, it provides laboratory instruments and reagents for clinical and research applications.

    RAINDANCE TECHNOLOGIES

    Raindance Technologies is a United States-based private company founded in 2004 with 104 employees. It develops digital PCR and microfluidic technologies for genomic analysis and molecular diagnostics.

    HALMA PLC

    Halma PLC is a United Kingdom-based public company founded in 1894 with 9,000 employees. It operates as a diversified group providing safety, environmental, and life sciences solutions across multiple markets.

    X-FAB

    X-FAB is a Germany-based public company founded in 1992 with 4,300 employees. It is a specialty semiconductor foundry providing analog and mixed-signal semiconductor manufacturing services.

    TECHNICOLOR SA

    Technicolor SA is a France-based public company founded in 1985 with 1,552 employees. It provides media and entertainment technology services including post-production, digital cinema, and content delivery solutions.

    MAXCYTE, INC

    MaxCyte, Inc. is a United States-based public company founded in 1998 with 91 employees. It develops electroporation technology platforms for cell engineering and therapeutic applications.

    DANAHER CORPORATION

    Danaher Corporation is a United States-based public company founded in 1969 with 59,000 employees. It operates as a diversified conglomerate providing products and services in life sciences, diagnostics, environmental, and applied solutions.

    ILLUMINA, INC.

    Illumina, Inc. is a United States-based public company founded in 1998 with 8,625 employees. It is a leading provider of DNA sequencing and array-based solutions for genomic analysis.

    BIOMÉRIEUX

    bioMérieux is a France-based public company founded in 1963 with 14,894 employees. It specializes in in vitro diagnostics and microbiology testing solutions for clinical and industrial applications.

    THERMO FISHER SCIENTIFIC INC.

    Thermo Fisher Scientific Inc. is a United States-based public company founded in 1956 with 125,000 employees. It is a global leader in serving science, providing laboratory equipment, reagents, software, and services for research and diagnostics.

    ABBOTT LABORATORIES

    Abbott Laboratories is a United States-based public company founded in 1888 with 115,000 employees. It is a diversified healthcare company providing pharmaceuticals, diagnostics, nutritional products, and medical devices.

    PARKER HANNIFIN CORP

    Parker Hannifin Corp is a United States-based public company founded in 1917 with 57,950 employees. It manufactures motion and control technologies including hydraulic, pneumatic, and electromechanical systems.

    SMC CORPORATION

    SMC Corporation is a United States-based public company founded in 1993 with 6,238 employees. It manufactures pneumatic and electric automation components and systems for industrial applications.

    IDEX CORPORATION

    IDEX Corporation is a United States-based public company founded in 1987 with 8,700 employees. It provides fluid and metering technologies, dispensing equipment, and safety systems for various industrial and life sciences applications.

    FORTIVE

    Fortive is a United States-based public company founded in 2015 with 10,000 employees. It operates as a diversified industrial technology conglomerate providing software, services, and equipment for manufacturing and infrastructure.

    REVVITY, INC.

    Revvity, Inc. is a United States-based public company founded in 1937 with 11,000 employees. It provides analytical instruments, software, and services for life sciences research, diagnostics, and environmental testing.

    AGILENT TECHNOLOGIES, INC.

    Agilent Technologies, Inc. is a United States-based public company founded in 1999 with 18,000 employees. It provides analytical instruments, software, and services for life sciences, diagnostics, and chemical analysis.

    BIO-RAD LABORATORIES, INC.

    Bio-Rad Laboratories, Inc. is a United States-based public company founded in 1952 with 7,450 employees. It manufactures and distributes life science research products and clinical diagnostics solutions.

    BECTON, DICKINSON AND COMPANY

    Becton, Dickinson and Company is a United States-based public company founded in 1897 with 72,000 employees. It is a global medical technology company providing medical devices, laboratory equipment, and diagnostic products.

    STANDARD BIOTOOLS

    Standard Biotools is a United States-based public company founded in 1999 with 387 employees. It develops microfluidic and single-cell analysis technologies for life sciences research and diagnostics.

    North America vs. other regions

    HowNorth America compares to the other 3 regional blocs covered in this market.

    Global
    ~USD 306 Million · 3.7% wtd CAGR ·

    Countries within North America - compare and drill down

    Country2025 size (native)
    USUSD 13146.8 Million
    CanadaUSD 2017.3 Million

    Country market size visualization

    US
    USD 13146.8 Million
    Canada
    USD 2017.3 Million

    Reasons to Buy this Report

    • Country-Level Market Segmentation : Access detailed market sizing for US ($13,146.8M) and Canada ($2,017.3M), enabling precise regional strategy development and competitive positioning within North America's distinct healthcare markets.
    • Growth Forecasting & Planning : Leverage 5-year projections (2025-2030) with 1.9% CAGR data to inform capital allocation, product development timelines, and market entry strategies tailored to North American maturity levels.
    • Competitive Benchmarking : Compare North America's 1.9% CAGR against global 8.3% growth to identify market saturation opportunities, differentiation strategies, and potential for innovation-driven market share gains.
    • Regulatory & Market Intelligence : Understand North America's established regulatory environment and mature adoption patterns to navigate FDA compliance, reimbursement pathways, and clinical integration requirements effectively.
    • Investment Decision Support : Make informed funding and M&A decisions with comprehensive North American market data, identifying growth pockets in Canada and emerging applications within the established US market.

    Frequently asked questions

    What is the market size of Other Microfluidic Components in 2025?

    Other Microfluidic Components are valued at $104.6 million in 2025, representing a specialized segment within the global microfluidics market.

    What is the projected market size for Other Microfluidic Components by 2030?

    Other Microfluidic Components are forecast to reach $114.9 million by 2030, reflecting a compound annual growth rate of 1.9%.

    Why is the growth rate of Other Microfluidic Components lower than the overall microfluidics market?

    Other Microfluidic Components grow at 1.9% CAGR compared to the overall market's 8.3% CAGR due to market maturation, integration of functions into unified platforms, and saturation in certain application segments.

    What applications drive demand for Other Microfluidic Components?

    Other Microfluidic Components are essential for point-of-care testing, lab-on-chip systems, pharmaceutical development, personalized medicine, and decentralized diagnostic applications.

    What challenges does the Other Microfluidic Components segment face?

    Other Microfluidic Components face challenges from integrated microfluidic solutions that consolidate multiple functions, market saturation in mature applications, and competition from larger component manufacturers.

    RESEARCH METHODOLOGY

    Four main studies were done to estimate the market size of microfluidics. Secondary research was carried out to obtain data associated with the market, peer markets, and parent markets. After that, data was obtained from 3-5 secondary sources; the findings, assumptions, and sizing were confirmed through primary sources. Top-down and bottom-up approaches were utilized to gain insights on complete market size. After that, market breakdown and data triangulation were used to determine the market size of segments and subsegments.

    Secondary Research

    Directories, databases like D&B Hoovers, Factiva, white papers, Bloomberg Businessweek, annual reports, SEC filings, business filings and investor presentations are few of the important sources used in the secondary research. This helps in gaining fundamental details about prominent companies and market segmentation as per the industry trends at numerous levels and technological viewpoints related with the Microfluidics market.

    Primary Research

    The primary research compromised performing interviews from both the supply and demand sides to obtain quantitative and qualitative data. CEOs, area sales managers, territory sales managers, regional sales managers and other important officials from top businesses are the primary sources from the supply side. Physicians, researchers, department heads, and staff members from diagnostic centers, hospitals and research institutes were the primary sources from the demand side. The target of this study was to verify the conclusions and assumptions from secondary research by interacting with stakeholders directly.

    A breakdown of the primary respondents is provided below:

    *Others include sales managers, marketing managers, business development managers, product managers, distributors, and suppliers.

    Note: Companies are classified into tiers based on their total revenue. As of 2023, Tier 1 = >USD 1 billion, Tier 2 = < USD 500 million, and Tier 3 = < USD 100 million.

    To know about the assumptions considered for the study, download the pdf brochure

    Market Size Estimation

    The revenue share analysis of the major key players for the size of the Microfluidics market is given in this study. Primary and secondary research are used to find prominent players in the Microfluidics and to gain insights of their financials and market share. The primary research approach comprises extremely in-depth interviews with CEOs, directors, and senior marketing executives, while the secondary research procedure mostly relied on the annual and financial reports of major players. Segment-based technique was used to determine the global market value. The revenue details of significant solution and service suppliers was then applied to source these segmented revenues.

    The steps in the procedure  are

    • List the key global companies that are associated with the Microfluidics industry. Note the annual revenues of the players in the Microfluidics industry or the product category/business division.
    • As of 2024, it represents an important portion of the market based on revenue mapping of the key competitors. Extrapolation to the global value for the Microfluidics market.

    Data Triangulation

    The Microfluidics market was categorized into various segments and subsegments with the help of the above procedure. Then, data triangulation and the market segmentation process are carried out to ensure the accuracy of the data for each segment. Factors and trends from demand and supply sides were studied . Top-down and bottom-up approaches provide the outcome from the analysis of the Microfluidics market.

    Market Definition

    The microfluidics market includes products and technologies that are developed to analyse and regulate fluid volume through microfluidic devices and components. The market covers both the microfluidics components that are important for the working of microfluidics-based devices, such as lab-on-a-chip systems and diagnostic assays, as well as the devices. Microneedles, micropumps, flow and pressure sensors, controllers, and microfluidic valves are some of the important components of microfluidics-based device.Polymers, silicon, and glass are most often used in the development of these components. The market provides innovative technologies for effective and precise fluid management and analysis, which have beneficial applications in research and diagnostics.

    Stakeholders

    • Microfluidic product manufacturers
    • Microfluidic product distributors
    • Pharmaceutical companies
    • IVD manufacturers
    • In vitro diagnostic test (IVD) distributors
    • Research institutes
    • Contract manufacturing organizations (CMOs)
    • Contract research organizations (CROs)
    • Healthcare institutions (hospitals, medical schools, and outpatient clinics)
    • Government associations
    • Market research and consulting firms
    • Venture capitalists and investors

    Report Objectives

    • To define, describe, and forecast the microfluidics market by product, application, end-user, and region
    • To provide detailed information about the key factors influencing the market growth, such as drivers, restraints, opportunities, challenges, and industry trends
    • To strategically analyze the regulatory scenario, Porter’s five force analysis, value chain analysis, supply chain analysis, ecosystem map, and patent analysis
    • To analyze micromarkets with respect to individual growth trends, prospects, and contributions to the microfluidics market
    • To analyze market opportunities for stakeholders and provide details of the competitive landscape for key players
    • To profile the prominent players in this market and comprehensively analyze their market shares and core competencies
    • To strategically analyze the microfluidics market in five regions: North America, Europe, the Asia Pacific, Latin America, and the Middle East & Africa
    • To track and analyze competitive developments such as acquisitions, product launches, product approvals, partnerships, and expansions in the microfluidics market

     

    Get the Full Microfluidics Market Report

    Full forecast, segment splits, and company analysis for all Microfluidics Market.

    Download Sample Pages Buy Report

    METHODOLOGY

    Need a Tailored Report?

    Customize this report to your needs

    Get 10% FREE Customization

    Customize This Report
    Fact checked
    Cite this Research
    DMCA.com Protection Status